Aadi Bioscience Stock Analysis

Aadi Stock Analysis Notes

About 52.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.07. Some equities with similar Price to Book (P/B) outperform the market in the long run. Aadi Bioscience recorded a loss per share of 2.28. The entity had not issued any dividends in recent years. The firm had 1:15 split on the 27th of August 2021. Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. The company was incorporated in 2007 and is headquartered in Pacific Palisades, California. Aadi Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 67 people. For more info on Aadi Bioscience please contact David Lennon at 424 744 8055 or go to https://aadibio.com.

Aadi Bioscience Investment Alerts

Aadi Bioscience Upcoming and Recent Events

Aadi Largest EPS Surprises

View All Earnings Estimates

Aadi Bioscience Environmental, Social, and Governance (ESG) Scores

Aadi Stock Institutional Investors

Note, although Aadi Bioscience's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Aadi Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 73.55 M.

Aadi Profitablity

The company has Profit Margin (PM) of (2.46) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.49) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.49.

Management Efficiency

Aadi Bioscience has return on total asset (ROA) of (0.3527) % which means that it has lost $0.3527 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6595) %, meaning that it created substantial loss on money invested by shareholders. Aadi Bioscience's management efficiency ratios could be used to measure how well Aadi Bioscience manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.47. The current Return On Capital Employed is estimated to decrease to -0.64. As of now, Aadi Bioscience's Other Current Assets are increasing as compared to previous years. The Aadi Bioscience's current Non Current Assets Total is estimated to increase to about 9.5 M, while Intangible Assets are projected to decrease to under 3 M.

Technical Drivers

As of the 19th of January, Aadi Bioscience shows the mean deviation of 3.56, and Risk Adjusted Performance of 0.0927. Aadi Bioscience technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Aadi Bioscience Price Movement Analysis

Aadi Bioscience Insider Trading Activities

Aadi Bioscience Outstanding Bonds

Aadi Bioscience Predictive Daily Indicators

Aadi Bioscience Corporate Filings

Aadi Bioscience Forecast Models

Aadi Bioscience's time-series forecasting models are one of many Aadi Bioscience's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Aadi Bioscience's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Aadi Bioscience prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Aadi shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Aadi Bioscience. By using and applying Aadi Stock analysis, traders can create a robust methodology for identifying Aadi entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Aadi analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Aadi analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Aadi Bioscience stock analysis indicators help investors evaluate how Aadi Bioscience stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Aadi Bioscience shares will generate the highest return on investment. By understating and applying Aadi Bioscience stock analysis, traders can identify Aadi Bioscience position entry and exit signals to maximize returns.

When running Aadi Bioscience's price analysis, check to measure Aadi Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aadi Bioscience is operating at the current time. Most of Aadi Bioscience's value examination focuses on studying past and present price action to predict the probability of Aadi Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aadi Bioscience's price. Additionally, you may evaluate how the addition of Aadi Bioscience to your portfolios can decrease your overall portfolio volatility.